| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-389 | |
| Phytochemical name or plant extracts | Marrubium persicum extract | |
| PMID | 23317267 | |
| Literature evidence | AIM: Developing antitumor drugs from natural products is receiving increasing interest worldwide due to limitations and side effects of therapy strategies for the second leading cause of disease related mortality, cancer. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Methanolic extract | |
| Source of phytochemicals or plant Extracts | Marrubium persicum | |
| Geographical availability | Iran, Transcaucasus, Turkey | |
| Plant parts | Aerial parts | |
| Other cancers | Breast cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | The antioxidant assay revealed that the extract was a strong scavenger of DPPH radicals with an RC50 value of 52 μg/mL. | |
| Cell line/ mice model | MCF-7 | |
| Additional information | Overall, M. persicum possesses potential antiproliferative and antioxidant activities on the malignant MCF-7 cell line that could be attributed to the high content of phenolics and flavonoids, and therefore warrants further exploration. | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:449946-1 | |
| Safety | NA |